TriSalus Life Sciences, Inc. (TLSI)
USD 5.2
(-0.38%)
USD 5.2
(-0.38%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 25.72 Million USD | 16.96% |
| 2022 | 21.99 Million USD | -41.87% |
| 2021 | 37.83 Million USD | -84.99% |
| 2020 | 252.01 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 17.88 Million USD | -30.46% |
| 2024 Q2 | 32.43 Million USD | 81.29% |
| 2023 FY | 25.72 Million USD | 16.96% |
| 2023 Q1 | 19.84 Million USD | -9.79% |
| 2023 Q4 | 25.72 Million USD | -23.33% |
| 2023 Q3 | 33.55 Million USD | 99.6% |
| 2023 Q2 | 16.81 Million USD | -15.28% |
| 2022 Q4 | 21.99 Million USD | -91.25% |
| 2022 FY | 21.99 Million USD | -41.87% |
| 2022 Q3 | 251.32 Million USD | 0.31% |
| 2022 Q2 | 250.55 Million USD | 0.06% |
| 2022 Q1 | 250.4 Million USD | -0.05% |
| 2021 Q4 | 250.53 Million USD | -0.09% |
| 2021 FY | 37.83 Million USD | -84.99% |
| 2021 Q2 | 251.2 Million USD | -0.23% |
| 2021 Q3 | 250.76 Million USD | -0.18% |
| 2021 Q1 | 251.79 Million USD | 0.72% |
| 2020 Q3 | 67.5 Thousand USD | 0.0% |
| 2020 Q4 | 250 Million USD | 370275.26% |
| 2020 FY | 252.01 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 17.984% |
| BrainsWay Ltd. | 62.97 Million USD | 59.149% |
| Cerus Corporation | 197.74 Million USD | 86.991% |
| Envoy Medical, Inc. | 7.64 Million USD | -236.715% |
| electroCore, Inc. | 16.38 Million USD | -56.984% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -234.438% |
| IceCure Medical Ltd | 16.41 Million USD | -56.764% |
| Inogen, Inc. | 326.19 Million USD | 92.114% |
| OrthoPediatrics Corp. | 449.58 Million USD | 94.278% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 5.666% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -55.166% |
| MaxCyte, Inc. | 268.27 Million USD | 90.411% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -217.698% |
| Nexalin Technology, Inc. | 3.63 Million USD | -608.304% |
| Orthofix Medical Inc. | 925.31 Million USD | 97.22% |
| PAVmed Inc | 33.11 Million USD | 22.326% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 82.067% |
| RxSight, Inc. | 182.55 Million USD | 85.908% |
| Sight Sciences, Inc. | 166.65 Million USD | 84.564% |
| SI-BONE, Inc. | 230.42 Million USD | 88.836% |
| TELA Bio, Inc. | 78.04 Million USD | 67.04% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 89.788% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -139.748% |
| Acutus Medical, Inc. | 53.96 Million USD | 52.326% |
| Talis Biomedical Corporation | 98.34 Million USD | 73.841% |
| Spectral AI, Inc. | 10.69 Million USD | -140.6% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 88.235% |
| CVRx, Inc. | 115.22 Million USD | 77.675% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 56.146% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -725.776% |
| Bioventus Inc. | 810.91 Million USD | 96.828% |
| Venus Concept Inc. | 93.65 Million USD | 72.532% |
| LivaNova PLC | 2.42 Billion USD | 98.941% |
| 908 Devices Inc. | 202.98 Million USD | 87.326% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 96.805% |
| Nemaura Medical Inc. | 14.56 Million USD | -76.643% |
| NeuroPace, Inc. | 107.65 Million USD | 76.103% |
| LENSAR, Inc. | 69.58 Million USD | 63.031% |
| Apyx Medical Corporation | 79.24 Million USD | 67.535% |
| Cutera, Inc. | 346.29 Million USD | 92.571% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 38.773% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1330.756% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 90.494% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 39.699% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.32% |
| Axonics, Inc. | 719.92 Million USD | 96.427% |
| Outset Medical, Inc. | 313.8 Million USD | 91.802% |
| IRIDEX Corporation | 34.43 Million USD | 25.296% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 93.644% |
| IRadimed Corporation | 92.15 Million USD | 72.085% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -389.627% |
| INVO Bioscience, Inc. | 20.88 Million USD | -23.158% |
| Telesis Bio, Inc. | 70.41 Million USD | 63.465% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 83.307% |
| Varex Imaging Corporation | 1.24 Billion USD | 97.941% |
| Quipt Home Medical Corp. | 247.4 Million USD | 89.602% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -176.316% |
| Pulmonx Corporation | 178.95 Million USD | 85.625% |
| Dynatronics Corporation | 25.94 Million USD | 0.831% |
| Modular Medical, Inc. | 13.8 Million USD | -86.319% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -139.815% |
| Semler Scientific, Inc. | 78.06 Million USD | 67.047% |
| InMode Ltd. | 863.28 Million USD | 97.02% |
| Bruker Corporation | 4.24 Billion USD | 99.395% |
| Cytosorbents Corporation | 53.26 Million USD | 51.7% |
| DexCom, Inc. | 6.26 Billion USD | 99.589% |
| Align Technology, Inc. | 6.08 Billion USD | 99.577% |
| Viveve Medical, Inc. | 25.91 Million USD | 0.726% |
| ZimVie Inc. | 1.2 Billion USD | 97.866% |
| Movano Inc. | 9.42 Million USD | -173.06% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 94.831% |
| Nexalin Technology, Inc. | 3.63 Million USD | -608.304% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 56.146% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 97.3% |
| Profound Medical Corp. | 43.68 Million USD | 41.114% |
| Insulet Corporation | 2.58 Billion USD | 99.006% |
| enVVeno Medical Corporation | 48.63 Million USD | 47.106% |
| Surmodics, Inc. | 185.73 Million USD | 86.149% |
| iCAD, Inc. | 41.41 Million USD | 37.889% |
| Nuwellis, Inc. | 9.77 Million USD | -163.306% |
| Biotricity, Inc. | 5.94 Million USD | -332.89% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 94.061% |
| Aethlon Medical, Inc. | 8.24 Million USD | -211.97% |
| InspireMD, Inc. | 47.64 Million USD | 46.005% |
| PAVmed Inc. | 33.11 Million USD | 22.326% |
| BIOLASE, Inc. | 35.1 Million USD | 26.711% |
| Beyond Air, Inc. | 56.96 Million USD | 54.838% |
| FONAR Corporation | 214.24 Million USD | 87.993% |
| AxoGen, Inc. | 196.82 Million USD | 86.93% |
| Vivani Medical, Inc. | 45.79 Million USD | 43.828% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 90.859% |
| Inari Medical, Inc. | 674.23 Million USD | 96.185% |
| UFP Technologies, Inc. | 404.13 Million USD | 93.635% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -9.943% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -170.701% |
| Tenon Medical, Inc. | 6.34 Million USD | -305.437% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -173.467% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 75.18% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.443% |
| Sintx Technologies, Inc. | 15.36 Million USD | -67.426% |
| NanoVibronix, Inc. | 6.67 Million USD | -285.451% |
| Quanterix Corporation | 425.01 Million USD | 93.947% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -176.316% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 52.119% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.527% |
| TransMedics Group, Inc. | 706.04 Million USD | 96.356% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 59.291% |
| NeuroMetrix, Inc. | 21.42 Million USD | -20.073% |
| Hyperfine, Inc. | 94.19 Million USD | 72.691% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 90.424% |
| Biomerica, Inc. | 9.25 Million USD | -177.988% |
| Bone Biologics Corporation | 3.73 Million USD | -588.246% |
| AVITA Medical, Inc. | 144.33 Million USD | 82.177% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -428.393% |
| Silk Road Medical, Inc | 265.3 Million USD | 90.304% |